Policy Priorities

Our Company

Policy Priorities

April 24, 2024

Catalyzing innovation through IP >

March 21, 2024

New EU HTA system for medicines must work for innovators and patients >

February 26, 2024

For healthcare to be sustainable, it must work for innovators, healthcare systems and patients >

January 24, 2024

Future-proofed regulation in the EU is vital to spur innovation in medicines >

November 20, 2023

Realizing the cell therapy revolution >

November 15, 2023

Closing Europe’s cancer gap by working together should be a health equity imperative >